Visen Pharmaceuticals (T06) Stock Price & News

All values in CNY	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	-375.50K	-375.50K	17.41M	17.41M
Cost of goods sold	73.00K	73.00K	8.24M	8.24M
Cost of revenue	73.00K	73.00K	8.24M	8.24M
Research and development expenses	23.43M	23.43M	18.69M	18.69M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	43.14M	43.14M	34.69M	34.69M
Operating expense	66.57M	66.57M	53.37M	53.37M
Total operating expenses	66.65M	66.65M	61.61M	61.61M
Operating income	-67.02M	-67.02M	-44.21M	-44.21M
Other non operating income	-306.50K	-306.50K	-500.00	-500.00
EBT including unusual items	-67.70M	-67.70M	-52.05M	-52.05M
EBT excluding unusual items	-67.70M	-67.70M	-52.05M	-52.05M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-67.70M	-67.70M	-52.05M	-52.05M
Net profit margin	18,029.56%	18,029.56%	-299.04%	-299.04%
Earnings per share	-	-	-	-
Interest and investment income	3.32M	3.32M	2.38M	2.38M
Interest expense	-529.50K	-529.50K	-1.02M	-1.02M
Net interest expenses	2.79M	2.79M	1.37M	1.37M
Depreciation and amortization charges	-	-	-	-
EBITDA	-66.91M	-66.91M	-44.01M	-44.01M
Gain or loss from assets sale	-	-	-	-

Finance